tiprankstipranks
Hca Healthcare (CH:2BH)
NYSE:2BH

HCA Healthcare (2BH) Price & Analysis

0 Followers

2BH Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Bulls Say, Bears Say

Bulls Say
Strong Cash GenerationHCA generates substantial and recurring operating cash flow and free cash flow, providing durable funding for capex, debt service, share repurchases and dividends. This cash convertibility supports strategic flexibility, resilience through cyclical volume swings and continued reinvestment over the medium term.
Large, Expanding Care NetworkHCA’s scale and steady network expansion strengthen competitive positioning via referral density, outpatient conversion and cross‑site efficiencies. Incremental bed and ER capacity plus site growth improve market reach and service mix, supporting sustainable volume capture and unit-cost leverage over months to years.
Solid Underlying ProfitabilityMargins and operating profitability are robust for a healthcare services operator, reflecting durable pricing power, case-mix and hospital-level economics. Stable revenue and positive EPS trends indicate the business model sustains cash generation and supports reinvestment even amid cyclical volume shifts.
Bears Say
Weak Balance Sheet / Negative EquityPersistent negative equity and material indebtedness constrain financial flexibility, increase refinancing and covenant risk, and make capital markets access more sensitive to shocks. This structural balance-sheet weakness limits capacity for large acquisitions or aggressive buybacks without increasing leverage risk.
Exchange And Uninsured Payer PressureWorsening payer mix from exchanges and higher uninsured volumes exerts durable downward pressure on realized prices and margins. The company faces a multi‑hundred‑million-dollar EBITDA headwind potential that can persist if enrollment patterns or reimbursement dynamics don’t normalize, challenging margin stability.
Sustained Volume And Denials HeadwindsSignificant declines in high‑acuity respiratory cases and softer surgical/outpatient volumes reduce high‑margin revenue and disrupt facility utilization. Rising denials and underpayments increase administrative costs and recovery risk, pressuring operating margins and productivity over the medium term.

HCA Healthcare News

2BH FAQ

What was Hca Healthcare’s price range in the past 12 months?
Currently, no data Available
What is Hca Healthcare’s market cap?
Hca Healthcare’s market cap is CHF70.34B.
    When is Hca Healthcare’s upcoming earnings report date?
    Hca Healthcare’s upcoming earnings report date is Jul 23, 2026 which is in 25 days.
      How were Hca Healthcare’s earnings last quarter?
      Hca Healthcare released its earnings results on Apr 24, 2026. The company reported $5.803 earnings per share for the quarter, beating the consensus estimate of $5.782 by $0.021.
        Is Hca Healthcare overvalued?
        According to Wall Street analysts Hca Healthcare’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Hca Healthcare pay dividends?
          Hca Healthcare does not currently pay dividends.
          What is Hca Healthcare’s EPS estimate?
          Hca Healthcare’s EPS estimate is 5.97.
            How many shares outstanding does Hca Healthcare have?
            Currently, no data Available
            What happened to Hca Healthcare’s price movement after its last earnings report?
            Hca Healthcare reported an EPS of $5.803 in its last earnings report, beating expectations of $5.782. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Hca Healthcare?
              Currently, no hedge funds are holding shares in CH:2BH
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                HCA Healthcare Stock Smart Score

                Company Description

                Hca Healthcare

                HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.

                HCA Healthcare (2BH) Earnings & Revenues

                2BH Earnings Call

                Q1 2026
                0:00 / 0:00
                Earnings Call Sentiment|Positive
                The call communicated a majority of positive operating and financial developments—revenue growth (+4.3%), strong EPS expansion (~11%), robust cash flow (+22%), sizable share repurchases, and a $200M incremental benefit from Medicaid supplemental programs—while acknowledging several meaningful headwinds including a sharp decline in respiratory-driven volumes, a January winter storm (combined ~$180M EBITDA drag), exchange-related revenue pressure (~$150M Q1; $600M–$900M full-year range), margin compression (‑50 bps) and rising denials. Management characterized the respiratory and weather impacts as temporal, reiterated full-year guidance and reaffirmed resiliency and AI-driven cost-efficiency plans. On balance, the company reported core growth and reinforced confidence in its balance sheet and guidance but faces significant payer and volume dynamics to monitor.View all CH:2BH earnings summaries

                2BH Revenue Breakdown

                28.15%28.15%32.68%34.98%4.19%
                28.15% National Group
                32.68% Atlantic Group
                34.98% American Group
                4.19% Corporate and other
                tipranks

                2BH Stock 12 Month Forecast

                Average Price Target

                $395.72
                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
                Similar Stocks
                Company
                Price & Change
                Follow
                DaVita
                Fresenius Medical Care
                Encompass Health
                Tenet Healthcare
                Universal Health
                Popular Stocks